SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 348 filers reported holding SEATTLE GENETICS INC in Q1 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,536,000 | -63.0% | 18,072 | -67.9% | 0.01% | -70.8% |
| Q2 2020 | $9,566,000 | +168.3% | 56,296 | +82.2% | 0.05% | +108.7% |
| Q1 2020 | $3,566,000 | +72.4% | 30,904 | +70.7% | 0.02% | +228.6% |
| Q4 2019 | $2,069,000 | +404.6% | 18,106 | +205.6% | 0.01% | +600.0% |
| Q2 2019 | $410,000 | -47.2% | 5,924 | -44.1% | 0.00% | -66.7% |
| Q1 2019 | $776,000 | +98.0% | 10,589 | +53.1% | 0.00% | +50.0% |
| Q4 2018 | $392,000 | -69.8% | 6,917 | -58.9% | 0.00% | -60.0% |
| Q3 2018 | $1,296,000 | +130.2% | 16,814 | +98.4% | 0.01% | +150.0% |
| Q2 2018 | $563,000 | -19.9% | 8,476 | -36.9% | 0.00% | -33.3% |
| Q1 2018 | $703,000 | – | 13,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |